Rein Therapeutics Inc. (RNTX)

Rein Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	17.65	17.31	5.19	3.6	7.05	5.31
Short-Term Investments	-	-	16.05	42.33	6.76	12.97
Cash & Short-Term Investments	17.65	17.31	21.24	45.93	13.81	18.28
Cash Growth	46.26%	-18.50%	-53.75%	232.73%	-24.47%	-11.68%
Prepaid Expenses	0.25	0.88	0.61	2.22	1.93	1.25
Restricted Cash	0.03	0.03	0.03	0.03	0.59	0.03
Other Current Assets	0.76	0.05	-	-	-	-
Total Current Assets	18.68	18.27	21.87	48.18	16.33	19.55
Property, Plant & Equipment	0	0.02	0.11	0.28	0.02	6.36
Goodwill	6.33	6.33	-	-	-	-
Other Intangible Assets	79.2	79.2	-	-	-	-
Other Long-Term Assets	0	2.19	0.02	0.02	-	0.57
Total Assets	104.22	106.01	22.01	48.48	16.34	26.47
Accounts Payable	1.08	1.19	1.72	1.21	1.6	1.45
Accrued Expenses	4.51	2.94	1.45	3.15	1.95	3.59
Current Portion of Long-Term Debt	-	-	-	-	0.17	-
Current Portion of Leases	-	0.05	0.03	0.09	-	0.45
Other Current Liabilities	0.07	0.21	0.18	0.06	0.24	0.35
Total Current Liabilities	5.66	4.39	3.38	4.51	3.96	5.84
Long-Term Debt	-	-	-	-	0.22	-
Long-Term Leases	-	-	-	0.07	-	4.59
Long-Term Deferred Tax Liabilities	3.33	3.33	-	-	-	-
Total Liabilities	8.99	7.71	3.38	4.58	4.18	10.43
Common Stock	0.11	0.09	0.09	0.09	0.04	0.03
Additional Paid-In Capital	360.56	295.38	291.37	289.28	231.41	214.15
Retained Earnings	-310.42	-288.52	-272.79	-245.46	-219.29	-198.14
Comprehensive Income & Other	-0.03	-0.06	-0.05	-0.01	-0	0.01
Total Common Equity	50.23	6.89	18.62	43.9	12.16	16.05
Shareholders' Equity	95.23	98.3	18.62	43.9	12.16	16.05
Total Liabilities & Equity	104.22	106.01	22.01	48.48	16.34	26.47
Total Debt	-	0.05	0.03	0.16	0.39	5.03
Net Cash (Debt)	17.65	17.27	21.21	45.77	13.42	13.25
Net Cash Growth	46.26%	-18.60%	-53.66%	241.12%	1.30%	-35.99%
Net Cash Per Share	1.29	3.75	4.67	10.31	7.70	10.80
Filing Date Shares Outstanding	21.67	16.97	4.54	4.53	4.51	1.39
Total Common Shares Outstanding	21.67	4.89	4.54	4.53	2.19	1.39
Working Capital	13.03	13.88	18.49	43.67	12.37	13.71
Book Value Per Share	2.32	1.41	4.10	9.69	5.55	11.54
Tangible Book Value	-35.3	-78.64	18.62	43.9	12.16	16.05
Tangible Book Value Per Share	-1.63	-16.10	4.10	9.69	5.55	11.54
Machinery	-	0.38	0.34	0.34	-	0.82

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q